Riskpilot← Back to searchSign inGet full accessS2Medical AB (publ)
ABActiveOrg 5569348344Sunnorpsgatan 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 20137 employees
Revenue 2024
SEK 14,7M
+111% vs 2023
EBITDA margin
42.1%
+146% vs 2023
Equity ratio
75.2%
Financial strength
Net profit 2024
SEK 5,2M
+124% vs 2023
| Revenue | SEK 14,7M | +111% |
| EBITDA | SEK 6,2M | +146% |
| Net profit | SEK 5,2M | +124% |
| Total assets | SEK 26,6M | +19% |
| Equity | SEK 20M | +689% |
| Employees | 7 | — |
Legal name
S2Medical AB (publ)
Org number
5569348344
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 juni 2013
Share capital
SEK 1 465 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av Sivlér, Inge Petter i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Då minst halva antalet styrelseledamöter ska vara bosatta inom EES uppfyller företaget inte kravet på bosättning.
Company purpose
Företaget skall verka för tillverkning, utveckling, import, export, marknadsföring och försäljning av medicintekniska produkter, kosmetika och läkemedel, samt bedriva verksamhet inom hälso- och sjukvård, utföra konsultuppdrag och handel med värdepapper.
Address
Sunnorpsgatan 5
Email
hello@s2m.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 25 616 | 7 700 | 4 670 | 6 971 | 14 677 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −13 645 | −18 318 | −25 765 | −13 457 | 6 180 |
| Depreciation & amort. | −1 291 | −1 290 | −1 524 | −1 349 | −931 |
| EBIT | −14 936 | −19 608 | −27 289 | −14 806 | 5 249 |
| Net financials | −73 | −243 | −1 768 | −7 444 | −17 |
| Profit before tax | −15 009 | −19 851 | −29 057 | −22 249 | 5 232 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −15 009 | −19 851 | −29 057 | −22 249 | 5 232 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 41 243 | 29 561 | 25 599 | 22 395 | 26 624 |
| Equity | 32 766 | 14 702 | 7 489 | 2 537 | 20 016 |
| Long-term debt | 208 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 269 | 14 860 | 18 110 | 19 859 | 6 608 |
| Total debt | 8 477 | 14 860 | 18 110 | 19 859 | 6 608 |
EBITDA margin
42.1%
This company
15.8%
Market median
+166% vs market
20202024
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
35.6%
This company
8.1%
Market median
+340% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
IP Chief Executive Officer | Chief Executive Officer | 2020 |
CM Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
CG | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
| Former (5) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2022 – 2022 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
S2Medical AB (publ) 
Curenc ABBoard members of S2Medical AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inge Petter Sivlér | Chief Executive Officer | 0 companies |
| Carl Mårten Andreas Skog | Deputy Chief Executive Officer | 0 companies |
| Carl-Johan Georg Sandberg | Audit | 0 companies |
| Göran Fredrik Skog | Chairman | 0 companies |
| Patrick Voltaire Sheehan | Board of Directors | 0 companies |
| Inge Teodor Vilhard Sivlér | Deputy Board Member | 0 companies |
| Carsten Nils Erik Browall | Board of Directors | 0 companies |
| Sadi Asaad | Board of Directors | 0 companies |
| Miles Corbett Wright | Board of Directors | 0 companies |
| Nina Veronica Bake | Chairman | 0 companies |
| Amin Hassanpour Omrani | Chairman | 0 companies |
| Nils Martin Zetterström | Board of Directors | 0 companies |